Medicxi Ventures Management’s Synthorx, Inc. Common Stock THOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,005,184
Closed -$70.3M 4
2019
Q4
$70.3M Buy
+1,005,184
New +$28.7M 43.05% 1

Medicxi Ventures Management's THOR Position: Q1 2020 in Review

Medicxi Ventures Management sold out of Synthorx, Inc. Common Stock (THOR) in Q1 2020, closing a stake of 1,005,184 shares — an estimated $70.3M sold.

Medicxi Ventures Management first reported a position in THOR in Q4 2019 and held it in 1 quarter. The position peaked at $70.3M in Q4 2019. 0 funds tracked by Wall St. Rank hold THOR as of Q1 2020.

  • Medicxi Ventures Management reported no remaining Synthorx, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Medicxi Ventures Management sold 1,005,184 Synthorx, Inc. Common Stock shares in Q1 2020, an estimated $70.3M.
  • Medicxi Ventures Management first reported a position in Synthorx, Inc. Common Stock in Q4 2019 and held it in 1 quarter.
  • Medicxi Ventures Management's Synthorx, Inc. Common Stock position peaked at $70.3M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Synthorx, Inc. Common Stock as of Q1 2020.

Based on Medicxi Ventures Management's 13F filing for Q1 2020, filed 12 May 2020.